The draft guidance addresses concerns that pulse oximeters are less accurate for people with dark skin tones. Experts raised ...
Deciding which risk to tolerate has long been the F.D.A.’s role, but rising external pressures are making that decision more ...
The founding director of the FDA’s Office of Biotechnology writes that, with FDA approval of medications ultimately vested ...
At the recent CBER agency workshop on cell therapies and tissue-based products, a few surprising ideas discussed could have ...
Swiss pharmaceutical company Roche announced Friday it will open an innovation center in the Harvard University Enterprise ...
Shares of Boston Scientific Corp. BSX slipped 1.66% to $99.13 Friday, on what proved to be an all-around great trading ...
Critics of seed oils, like RFK Jr., say they are toxic and fueling high rates of chronic diseases. Such claims baffle ...
The Swiss pharma will base cardiometabolic drug research at the new Allston site. Elsewhere, AskBio advanced a gene therapy ...
Boston Scientific has led a $175 million funding round for the mitral valve developer 4C Medical, which is currently working ...
A polarizing New York policy to treat people with mental illness is ineffective and racially biased, according to a report ...
Chemicals such as titanium dioxide and potassium bromate, whose safety has been debated, are allowed in foods in the United ...
Dr. Marty Makary, President Trump's pick to run the Food and Drug Administration, faced questions from the Senate HELP ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback